| Schedule of Cash Equivalents and Available-for-Sale Marketable Securities |
Cash equivalents and available-for-sale marketable securities included the following as of June 30, 2026 and December 31, 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized Losses |
|
|
|
|
Amortized
Cost |
|
|
Unrealized
Gains |
|
|
Less than
12 months |
|
|
Greater than
12 months |
|
|
Fair Value |
|
|
|
(in thousands) |
|
As of June 30, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
|
24,548 |
|
|
$ |
|
— |
|
|
$ |
|
— |
|
|
$ |
|
— |
|
|
$ |
|
24,548 |
|
Marketable securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury notes |
|
|
|
40,002 |
|
|
|
|
15 |
|
|
|
|
(3 |
) |
|
|
|
(83 |
) |
|
|
|
39,931 |
|
U.S. Government agency securities |
|
|
|
24,067 |
|
|
|
|
— |
|
|
|
|
(17 |
) |
|
|
|
(110 |
) |
|
|
|
23,940 |
|
Corporate bonds |
|
|
|
43,466 |
|
|
|
|
2 |
|
|
|
|
(46 |
) |
|
|
|
(51 |
) |
|
|
|
43,371 |
|
Commercial paper |
|
|
|
5,803 |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
5,803 |
|
Total cash equivalents and marketable securities |
|
$ |
|
137,886 |
|
|
$ |
|
17 |
|
|
$ |
|
(66 |
) |
|
$ |
|
(244 |
) |
|
$ |
|
137,593 |
|
As of December 31, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
|
51,161 |
|
|
$ |
|
— |
|
|
$ |
|
— |
|
|
$ |
|
— |
|
|
$ |
|
51,161 |
|
Commercial paper |
|
|
|
3,477 |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
3,477 |
|
Marketable securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury notes |
|
|
|
72,665 |
|
|
|
|
141 |
|
|
|
|
(1 |
) |
|
|
|
— |
|
|
|
|
72,805 |
|
U.S. Government agency securities |
|
|
|
15,376 |
|
|
|
|
18 |
|
|
|
|
— |
|
|
|
|
(7 |
) |
|
|
|
15,387 |
|
Corporate bonds |
|
|
|
44,251 |
|
|
|
|
19 |
|
|
|
|
(10 |
) |
|
|
|
— |
|
|
|
|
44,260 |
|
Commercial paper |
|
|
|
3,939 |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
3,939 |
|
Total cash equivalents and marketable securities |
|
$ |
|
190,869 |
|
|
$ |
|
178 |
|
|
$ |
|
(11 |
) |
|
$ |
|
(7 |
) |
|
$ |
|
191,029 |
|
|
| Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash |
The following table provides a reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets that sum to the total of the same amounts shown in the condensed consolidated statements of cash flows:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, |
|
|
As of December 31, |
|
|
|
2026 |
|
|
2025 |
|
|
|
(in thousands) |
|
Cash and cash equivalents |
|
$ |
|
35,769 |
|
|
$ |
|
65,300 |
|
Restricted cash included in deposits and other non-current assets |
|
|
|
2,736 |
|
|
|
|
2,736 |
|
Total cash, cash equivalents, and restricted cash |
|
$ |
|
38,505 |
|
|
$ |
|
68,036 |
|
|